3D microtumors in vitro supported by perfused vascular networks
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors and stromal cells (endothelial cells) coexisted in these microvessels networks for up to 24 days.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tumors grew vigorously in the 3D extracellular matrix, depending for survival entirely on nutrient delivery through living, fully functional, and leak-free vasculature.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Remarkably, HCT116-cells growing in the vascularized microfluidic tumors exhibited chemoresistance to oxaliplatin that was one order higher than that shown by cells cultured in a 2D monolayer.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Specifically, this model allows for the creation of “vascularized micro-tumors” (VMTs), whereby the coculture of endothelial colony-forming cell-derived ECs, normal human lung fibroblasts and cancer cells under dynamic flow conditions enables the de novo formation of perfusable microvascular networks that surround the micro-tumors, supplying nutrients and therapeutics just as tumor-associated”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Sobrino et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The authors recreated, in a geometrically simple device (Figure 7e-i), a fully perfusable and complex vasculature network and was able to demonstrate the feasibility of culturing tumor spheroids for extended time periods.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Cited by
Items 301–388 of 388
Dibble, M., Ciò, S. D., Luo, P., Balkwill, F. R., & Gautrot, J. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.03.490457 · Cited by 6
Scemama, A., Lunetto, S., Tailor, A., Ciò, S. D., Dibble, M., Gautrot, J., & Biddle, A. (2023) · F1000Research · doi:10.12688/f1000research.131810.1 · Cited by 12
“This type of device has been used for other cancer types, including breast cancer, glioblastoma, colorectal cancer, etc. (Lee et al. , 2014; Jeon et al. , 2015; Sobrino et al. , 2016), demonstrating its suitability for metastasis studies regardless of the cancer cell origin.”
Progress in patient-derived liver cancer cell models: a step forward for precision medicine
Zhang, Z., & Hui, L. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023224 · Cited by 5
“Importantly, the vascularized cancer organoid-on-a-chip could be used for testing anti-vascular therapies [76].”
BackgroundMethods for processing and analyzing images of vascularized micro-organ and tumor systems
Hachey, S. J., Hatch, C. J., Gaebler, D., Forsythe, A. G., Ewald, M. L., Chopra, A. L., Chen, Z., Thapa, K., Hodanu, M., Fang, J. S., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1585003 · Cited by 5
Self-citationSaridis, M. R., Salmina, A. B., Korsakova, S. A., & Yurchenko, S. O. (2025) · Biotechnology Journal · doi:10.1002/biot.70065 · Cited by 6
Cells and Organs on a Chip in Biomedical Sciences
Roberts, A., Mahari, S., & Gandhi, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-1379-2_10 · Cited by 5
Goto, A., Moriya, Y., Nakayama, M., Iwasaki, S., & Yamamoto, S. (2024) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2024.101003 · Cited by 5
Customizable biomaterials as tools for advanced anti-angiogenic drug discovery
Nguyen, E. H., & Murphy, W. L. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.041 · Cited by 5
Song, J., Ko, J., Choi, N., Jeon, N. L., & Kim, H. N. (2023) · Organoid · doi:10.51335/organoid.2023.3.e6 · Cited by 5
Integration of systems biology with organs-on-chips to humanize therapeutic development
Edington, C., Cirit, M., Chen, W. L. K., Clark, A. M., Wells, A. H., Trumper, D. L., & Griffith, L. G. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2256078 · Cited by 5
Recovery of Therapeutically Ablated Engineered Blood‐Vessel Networks on a Plug‐and‐Play Platform
Krattiger, L. A., Moser, L. O., Odabasi, R., Odriozola, A., Simona, B. R., Djonov, V., Tibbitt, M. W., & Ehrbar, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301142 · Cited by 6
Hsu, Y., Yang, W.-C., Chen, Y.-T., Lin, C.-Y., Yang, C.-F., Liu, W., Shivani, S., & Li, P. (2024) · Lab on a Chip · doi:10.1039/d3lc00891f · Cited by 3
Hydrogel advancements in vascular tissue regeneration: a comprehensive review and future prospects
Elshabrawy, H. A., Moustafa, H. A., Yacoub, M. H., & El-sherbiny, I. M. (2024) · Emergent Materials · doi:10.1007/s42247-024-00678-1 · Cited by 6
“…networks [191] Gelatin, fibrin increased angiogenic sprouting and vascular leakage in microtumors that are vascularized and include tumor cells [192] GelMA, alginate, PEGOA Ionic crosslinking Creation of blood vessel tissue using hSMCs and HUVECs Significant increased mechanical strength…”
Ibrahim, R. S., El‐Wadood, H. M. A., El‐Zahry, M. R., & Hosny, N. M. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113137 · Cited by 4
Tan, S., Deng, J., Deng, H., Lu, L., Qin, Z., Liu, Y., Tang, L., & Li, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1253573 · Cited by 5
Varadarajan, S. N., Mathew, K. A., Chandrasekharan, A., Lupitha, S. S., Lekshmi, A., Mini, M., Darvin, P., & Santhoshkumar, T. R. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30222 · Cited by 4
“Another study demonstrated the importance of blood flow in drug response using an innovative approach of growing tumors with the intraluminal flow.(42) Experimental approaches as described here for visualizing cell cycle and cell death in 3D offer a great potential to study the impact of the tumor microenvironment, bi…”
BackgroundThe Managed Acquisition of Chemoresistance as an Informative Tool for Tumor Research
Grigoreva, T. A., Kindt, D. N., Sagaidak, A. V., Romanova, A. A., & Tribulovich, V. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110400 · Cited by 3
The application of 3D cell culture for melanoma in vitro models
Xu, K., Wu, J., Li, Z., Chen, W., Wei, P., & Wu, M. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.11.039 · Cited by 4
Lee, Y., Kim, S., Koh, H., Park, Y., Han, J. Y., & Ko, J. (2026) · Lab on a Chip · doi:10.1039/d5lc00893j · Cited by 4
Willi, C. E., Abdelazim, H., & Chappell, J. C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1008481 · Cited by 3
Lin, Y., Tung, Y., Wong, J.-Y., & Wang, G. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.111707 · Cited by 4
Lampejo, A. O., Lightsey, S. E., Gomes, M. C., Nguyen, C. M., Siemann, D. W., Sharma, B., & Murfee, W. L. (2024) · Annals of Biomedical Engineering · doi:10.1007/s10439-024-03535-8 · Cited by 5
Study of diffusive- and convective-transport mediated microtumor growth in a controlled microchamber
Hsu, Y., Liu, W., Wu, T.-H., Lee, C. J.-T., Chen, Y.-H., & Li, P. (2019) · Biomedical Microdevices · doi:10.1007/s10544-018-0356-7 · Cited by 3
Microvascular Networks and Models: In Vitro Formation
Blache, U., Guerrero, J., Güven, S., Klar, A. S., & Scherberich, A. (2021) · Reference series in biomedical engineering · doi:10.1007/978-3-319-54586-8_9 · Cited by 4
A Microphysiological HHT-on-a-Chip Platform Recapitulates Patient Vascular LesionsPreprint
Fang, J. S., Hatch, C. J., Andrejecsk, J. W., Trigt, W. K. V., Juat, D. J., Chen, Y., Matsumoto, S., Lee, A. P., & Hughes, C. C. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.11.584490 · Cited by 3
“…flow in our base VMO platform produces shear stress values of ~0.5 dynes/cm 2 -- clearly sufficient to support the formation of vessels-on-a-chip, 28 but apparently insufficient to support the development of AVMs (as evidenced by our finding that Alk1-deficient EC do not generate shunts in the…”
BackgroundMethodInfluentialSelf-citationJian, T., Sivitilli, A., Guo, Y. E., Stirton, C., Gosio, J., Tsukahara, Y., Tkach, J. M., Lu, S., Yarmand, A., Mangos, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.21.713033 · Cited by 4
Zhang, Q., Liu, H., Zhang, X., Wang, H., Lu, W., & Dai, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115449 · Cited by 2
Humayun, M., Jiménez‐Torres, J. A., Li, C., Ayuso, J. M., Lugo-Cintrón, K. M., Ulbrich, J., Myers, B., Kerr, S. C., Ahmed, A., & Beebe, D. J. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202500429 · Cited by 2
Wu, M., Xu, D., Dou, X., Zhou, Y., Lu, J., & Ge, Q. (2026) · Cell Signaling Inflammation & Disease · doi:10.1186/s44505-026-00004-y · Cited by 2
“Additionally, by incorporating multiple cell types, including cancer cells, fibroblasts, and immune cells, these systems enable investigation of tumor-stromal crosstalk and immune cell infiltration under controlled experimental conditions [51, 53, 54].”
Organ-specific colonization and niche remodeling in a human tissue model of metastasis
Chramiec, A. G., Baldassarri, I., Öztürk, E., Tavakol, D. N., Wang, M. C., Summers, M., Yeager, K. J., Zhuang, R. Z., Srivastava, A., Tagore, S., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adv6871 · Cited by 3
Three-dimensional in vitro models of angiogenesis
di Blasio, L., Vara-Messler, M., & Primo, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00008-3 · Cited by 2
A microphysiological system HHT-on-a-chip platform recapitulates patient vascular lesions
Fang, J. S., Hatch, C. J., Andrejecsk, J. W., Trigt, W. K. V., Gonzales, J. R., Juat, D. J., Looker, E. K., Harris, S. R., Chen, Y., Matsumoto, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76448-w · Cited by 6
“2c), consistent with how the microvasculature develops in our published VMO models 31,32,34,38 .”
InfluentialSelf-citationPerfusion-based 3D tumor-on-chip devices for anticancer drug testing
Dhiman, N., & Rath, S. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00016-2 · Cited by 3
Intestine-to-neuronal signaling alters risk-taking behaviors in food-deprived Caenorhabditis elegansPreprint
Matty, M. A., Lau, H. E., Singh, A., Haley, J. A., Chakraborty, A., Kono, K., Reddy, K. C., Hansen, M., & Chalasani, S. H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/156109 · Cited by 2
Cx40 Suppresses Sprouting Angiogenesis In Vitro
Looker, E. K., Aan, F. J., Hatch, C. J., Hughes, C. C. W., Matter, M. L., & Fang, J. S. (2023) · Bioelectricity · doi:10.1089/bioe.2023.0034 · Cited by 1
“19,20 In brief, fluorescent EC were co-seeded at a 1:1 ratio with primary human fibroblasts into an 8 mg/mL fibrin hydrogel within a VMO microfluidic device, and gravity driven interstitial flow of complete EGM2 was established.”
InfluentialSelf-citationMazari‐Arrighi, E., Boyreau, A., Chaillot, L., Souleyreau, W., Andrique, L., Guichet, P., Mathivet, T., Bikfalvi, A., & Nassoy, P. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71307 · Cited by 1
“Although culture is performed under static conditions, the in vitro monolayers remain structurally and cellularly stable for at least 30 days, surpassing the typical lifespan of many 3D endothelial models, which often degrade or delaminate within less than 2 weeks [60, 66–68].”
Recent advances of microfluidic organ-on-a-chip monitoring strategies
Ebrahimi, A., Benzait, Z., Tomsuk, Ö., Özel, C., Tüfekçioğlu, E., Dordinejad, G. G., Didarian, R., Ghorbanpoor, H., Güzel, F. D., & Avcı, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21519-3.00029-7 · Cited by 3
Free-floating long-term vascularized mesenchymal organoids
de Janon, A., Kaza, P. S., Yoshida, K., Lee, S., DeRyckere, D., Graham, D. K., & Takayama, S. (2025) · iScience · doi:10.1016/j.isci.2025.114548 · Cited by 3
“5 VMOs were enriched in several pathways involved in angiogenesis, vasculature, and endothelium development (Figure 3G) when compared to spheroids, suggesting that VMOs are more conducive to angiogenesis.”
Kameda, Y., Fujimoto, K., Yoshioka, M., Enoki, T., Yamashita, J. K., & Yokokawa, R. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.01.009 · Cited by 2
Zhang, X., Zhu, X., Chen, Y., & Lu, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1827951 · Cited by 2
Hu, X., Zhang, Y., Lu, Y., Zheng, F., Zhang, K., Jiang, M., Chen, C., Wei, Z., & Wang, J. (2026) · Small · doi:10.1002/smll.73850 · Cited by 2
Dai, Z., Fu, G., Du, Y., Xie, Y., ZHU, J., Tao, X., Luo, Q., Chu, X., & Lei, Z. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102873 · Cited by 3
Vascularized tumor organoids as models for interpreting therapeutic response
Huang, S., Han, S., & Wang, K. (2026) · Vascular Pharmacology · doi:10.1016/j.vph.2026.107673 · Cited by 1
Enabling Technologies in Vascular Biology: Microphysiological Systems, Organoids, and Beyond
Gholizadeh, H., & Benam, K. H. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.323054 · Cited by 1
Engineering a Perfusable Vascular Network in a Microfluidic Device for a Morphological Analysis
Nashimoto, Y., Teraoka, Y., Arima, Y., Hanada, S., Nakamasu, A. M., Kotera, H., Nishiyama, K., Miura, T., & Yokokawa, R. (2018) · IEEJ Transactions on Sensors and Micromachines · doi:10.1541/ieejsmas.138.275 · Cited by 1
Novel, Emerging Chip Models of the Blood-Brain Barrier and Future Directions
Holloway, P. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_11 · Cited by 1
Tissue chips as headway model and incitement technology
Modi, P. S., Singh, A., Chaturvedi, A., Agarwal, S., Dutta, R., Nayak, R., & Singh, A. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.08.007 · Cited by 2
“…while a reduction in blood vessels due to targeting of Vascular Endothelial Growth Factor and other receptors by Linifanib and Cabozantinib [76] Similarly, a microfluidic vascular micro-organs development platform was devised by Phan et al. for effectiveness evaluation of cancer drugs…”
MethodInnovative Stamp-Structured Organ-on-a-Chip Platform for Vascularized Tumor and Colon Models
Wang, F., Zhou, C., & Wang, X. L. (2025) · IEEE International Conference on Micro Electro Mechanical Systems (MEMS) · doi:10.1109/mems61431.2025.10918087 · Cited by 1
Self-citationAI-powered image standardization in microphysiological system platforms
Park, W., Kim, C., & Ko, J. (2025) · JMST Advances · doi:10.1007/s42791-025-00112-5 · Cited by 1
“2 [44, 45].”
Microvascular Networks and Models, In vitro Formation
Blache, U., Guerrero, J., Güven, S., Klar, A. S., & Scherberich, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-21056-8_9-1 · Cited by 3
On chip complex breast tumour microenvironment: application to research in nanomedicine
Blondé, J.-B. (2020) · doi:10.3990/1.9789036550598 · Cited by 1
Rajasekar, S., Lin, D. S. Y., Zhang, F., Sotra, A., Boshart, A., Clotet‐Freixas, S., Liu, A. W. K., Hirota, J. A., Ogawa, S., Konvalinka, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.13.456244 · Cited by 1
Ngo, M. T., Sarkaria, J. N., & Harley, B. A. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.27.489740 · Cited by 1
Microphysiological vascularized solid tumor model for drugs and cell therapies screeningPreprint
Reales‐Calderón, J. A., Lam, M. S. Y., Ow, J. R., Aw, J., Tan, D., Adriani, G., & Pavesi, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1853599/v1 · Cited by 1
Kurokawa, Y. K. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7db818f
“10 Microfluidic device fabrication and culture The microfluidic device were fabricated using standard soft lithography and replica molding techniques, as described previously.(230,275,289) The devices were cast of polydimethylsiloxane (PDMS), plasma bonded onto glass slides, and sterilized before cell loading.”
MethodMack, P. J., Khalil, A. S., Weinberg, E. J., Adamo, L., Slegtenhorst, B. R., Borenstein, J. T., & García‐Cardeña, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00010-4 · Cited by 1
Cho, S., Choi, H. S., Yang, J. E., & Suh, S. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9176552
“Also, in vitro-angiogenesis-chip represented equivalent reactions to pro-, and anti-angiogenic factors [11].”
BackgroundUnderstanding the impact of controlled oxygen delivery to 3D cancer cell culture
Grosh, D., Wulftange, W. J., Robey, R. W., Pohida, T. J., Morgan, N. Y., & Gottesman, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00027-7
Newly emerged engineering of in vitro 3D tumor models using biomaterials for chemotherapy
Cai, B., Lv, Q., Wang, Z., & Wang, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00022-8
Modeling metastasis: engineering approaches to study the metastatic cascade
Pruitt, H. C., & Gerecht, S. (2020) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/abc34f
“…however, the Hughes group assessed the effect of different anti-angiogenic therapies on tumor vascularization using a model containing vessel support cells and found that while sorafenib disrupted the development of newly formed vessels, vincristine disrupted entire vascular networks [84].”
Design of an Integrated Microvascularised Human Skin-on-a-Chip Tissue Equivalent ModelPreprint
Jones, C. F. E., Ciò, S. D., Connelly, J. T., & Gautrot, J. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.06.487276
Rojek, K. O., Wrzos, A., Żukowski, S., Bogdan, M. J., Lisicki, M., Szymczak, P., & Guzowski, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.02.555959
Singh, S. K., Ahuja, A., Ramankutty, R., & Ramaswamy, S. (2023) · Current Drug Therapy · doi:10.2174/0115748855266739230919110125
Wang, X., Zhao, H., Luo, X., Chen, Y., Shi, C., Wang, Y., Bai, J., Shao, Z., & Shang, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3642085/v1
Self-citationVascularization of organoids in microfluidic chips
Raji, R. G., Anjali, K., & Kumar, V. B. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00026-7
Baranowska, P., Flont, M., Żuchowska, A., Brzózka, Z., & Jastrzębska, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15978-7.00048-5
Rojek, K. O., Wrzos, A., Maiullari, F., Giżyński, K., Ceraolo, M. G., Bearzi, C., Rizzi, R., Szymczak, P., & Guzowski, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.20.655072
“…under well-defined and optimized adjacent bead-bead spacing constitutes an important step towards precision-engineering of interconnections in vascularized tissues, e.g., for future applications in perfusable organ-on-chip devices [5, 6, 40] or in fabrication of vascularized wound dressings.”
Non-Animal Technologies to Study and Target the Tumour Vasculature and Angiogenesis
Ferrero, E., Hue, J., Ferrarini, M., & Veschini, L. (2025) · Organoids · doi:10.3390/organoids4020012 · Cited by 1
3D bioprinting technology in cancer management: Applications, challenges, and future perspectives
Nandy, B. C., Dutta, S., Banerjee, B., & Mondal, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26518-1.00010-0
3D bioprinted models for antiangiogenic drug screening and validation
Chakraborty, G., Anand, S., Sahoo, K., Ichageri, A., Patra, C., & Swain, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26518-1.00009-4
Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663254
Self-citationHachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663260
Self-citationHachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663251
Self-citationHachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024) · Figshare · doi:10.6084/m9.figshare.26663257
Self-citationRojek, K. O., Wrzos, A., Maiullari, F., Giżyński, K., Ceraolo, M. G., Bearzi, C., Rizzi, R., Szymczak, P., & Guzowski, J. (2026) · Lab on a Chip · doi:10.1039/d5lc00664c
Modèles de vaisseaux sanguins sur puce pour l'étude des fonctions de la barrière endothéliale
Delannoy, E. (2021) · theses.fr (ABES) · doi:10.70675/c1aab157zdfc1z4179z9306zc6f4d4ffcd6f
Xu, Y., Wubuli, N., & Zhang, J. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11145-1
“Traditional avascular tumor spheroids entirely fail to capture this critical heterotypic crosstalk [92, 93].”
Moghimi, N., Rezaeian, M., & Kohandel, M. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108722
Endothelial Cell-Pericyte Crosstalk in the Brain Balances Microvascular Stability and Plasticity
Lee, J. M., Luc, E., & Stratman, A. N. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.323547 · Cited by 2
Hernández-Castro, J. A., Lussier, F., Malic, L., Geißler, M., Kim, T.-H., Moon, B., Li, K., Zhao, Y., Clime, L., Brassard, D., et al. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115945
Cretti, G., Ballerini, M., Mantegazza, A., Occhetta, P., & Rasponi, M. (2026) · Advanced Materials Technologies · doi:10.1002/admt.71277
Liu, Y., Wang, Y., Huang, X., Li, Y., zhu, A., Wang, M., Yao, H., & Liang, L. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108438
Pinon, L., Debache, A., Thuaud, A., Tiraboschi, L., Vella, G., Riou-Ramon, J., Cordier, C., Helal, C., Hersen, P., Rescigno, M., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10675-1
“Tobetterunderstandhowbacteriadisruptandmigratethroughvas-cularroutestocolonizedistanttissues,ToCscanbeintegratedwithvascular systemssurroundingcancercells 133 or tumoral organoids 208,209,213 – 215 .”
Tian, H., Li, G., Lian, Y., Liu, H., Fang, Y., Tong, Y., He, Z., Bian, Y., & Wei, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1926341
“Jeon et al. (2015) had the strongest burst, followed by Tsai et al. (2017), Shirure et al. (2018), and Sobrino et al. (2016).”
Zaman, M., NAZARE, T., Sarkar, A., & Mirzapourshafiyi, F. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124696
Gach, J. S., Kim, D., Vu, K., Marshall, M. E., Cachay, C., Rangwala, A. A., Kerster, G., Tifrea, D. F., Pearlman, E. M., Zahn, M., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014664
Self-citation
Metadata
- Authors
- Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 31589-31589
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4994029
- OpenAlex
- W2510834891
- Cited by
- 387
- References
- 58
- Citations by year
- 2026: 23 · 2025: 34 · 2024: 41 · 2023: 36 · 2022: 52 · 2021: 56 · 2020: 52 · 2019: 29 · 2018: 35 · 2017: 28 · 2016: 1
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Coordinating Council for Women in History
- National Institutes of Health (UH3TR000481, UL1TR001414, UH2TR000481)
- National Cancer Institute (R01CA170879, P30A062203, R01CA180122)
- National Center for Advancing Translational Sciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-on-a-chip, 3D extracellular matrix, colorectal cancer, breast cancer, tumor stroma, vascular targeting agents, VEGFR inhibitors, PDGFR inhibitors, metabolic heterogeneity, aerobic glycolysis, drug response
- MeSH terms
- Breast Neoplasms, Female, Humans, Male, Models, Biological, Neovascularization, Pathologic, Colorectal Neoplasms, Angiogenesis Inhibitors, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.